{"disease":{"id":"meningococcal-vaccine","name":"meningococcal vaccine"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05873751","title":"A Study to Learn About How Trumenba Vaccine Shots Work Against Gonorrhea Infection in Teenagers and Young Adults in the United States.","phase":"","overall_status":"COMPLETED","enrollment_count":1307378,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04664569","title":"National Bacterial Meningitis Study","phase":"","overall_status":"RECRUITING","enrollment_count":8230,"lead_sponsor_name":"Association Clinique Thérapeutique Infantile du val de Marne","has_results":false},{"nct_id":"NCT01461980","title":"A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to MCV4, Tdap and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 10 Through 12 Years of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2648,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01461993","title":"A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and Bivalent rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2499,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04440163","title":"MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2431,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01144663","title":"Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2095,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01299480","title":"A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1714,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03135834","title":"A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1610,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT00514904","title":"Non-Inferiority of Meningococcal Vaccine GSK134612 Versus Mencevax™ in 2-10 Year Old Subjects","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1504,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT01323270","title":"A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":753,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04645966","title":"A Clinical Trial to Assess the Safety, Tolerability and Immunogenicity of MenABCWY in Healthy Infants","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":326,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT04440176","title":"A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":309,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT01266993","title":"Persistence and Booster Study of GSK Biologicals' Meningococcal Vaccine (GSK134612) in Healthy Children","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":271,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT04819113","title":"Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03263403","title":"Non Inferiority Trial of Locally Manufactured Meningococcal ACWY Vaccine 'Ingovax ACWY' in Bangladesh.","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":88,"lead_sponsor_name":"International Centre for Diarrhoeal Disease Research, Bangladesh","has_results":false},{"nct_id":"NCT02810340","title":"Study of Meninigococcal Conjugate Vaccine Containing Serogroups A,C,Y,W and X (MCV5) in Healthy Adults","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"PATH","has_results":true},{"nct_id":"NCT04893811","title":"Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03509051","title":"Prospective Study on the Vaccine Response to Meningococcal B Vaccine After Allogeneic Stem Cell Transplantation","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false}],"total":18},"guidelines":[],"source":"Drug Landscape verified database"}